NCT03696771
- Conditions
- NON-breast HER2+ Malignancies
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
- Novartis Investigative Site Milan, MI, Italy
- Novartis Investigative Site Kashiwa, Chiba, Japan
- Novartis Investigative Site Seoul, South Korea